AIDS Treatment News logo      

September 30, 2009

Overview of ARV studies at IAS [July 19-22, 2009, in Cape Town, South Africa]

"The conference included a broad range of important studies that could inform use of currently approved drugs, and first results of a new integrase inhibitor.

"First results of new integrase compound: GSK1349572

...

"Raltegravir in treatment-naive patients

...

"Nevirapine vs atazanavir/ritonavir in treatment-naive patients: ARTEN study

...

"Darunavir/r monotherapy studies

...

Maraviroc results similar to efavirenz when analysed using more sensitive tropism test"


Read more in i-base, September/October 2009.

0 comments: